- Home
- PLNT vs LNTH Comparison
PLNT vs LNTH Comparison
Compare PLNT & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLNT
- LNTH
- Stock Information
- Founded
- PLNT 1992
- LNTH 1956
- Country
- PLNT United States
- LNTH United States
- Employees
- PLNT N/A
- LNTH N/A
- Industry
- PLNT Hotels/Resorts
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- PLNT Consumer Discretionary
- LNTH Health Care
- Exchange
- PLNT Nasdaq
- LNTH Nasdaq
- Market Cap
- PLNT 8.1B
- LNTH 7.5B
- IPO Year
- PLNT 2015
- LNTH 2015
- Fundamental
- Price
- PLNT $93.83
- LNTH $78.95
- Analyst Decision
- PLNT Buy
- LNTH Strong Buy
- Analyst Count
- PLNT 17
- LNTH 5
- Target Price
- PLNT $102.76
- LNTH $133.80
- AVG Volume (30 Days)
- PLNT 1.5M
- LNTH 1.3M
- Earning Date
- PLNT 05-08-2025
- LNTH 05-07-2025
- Dividend Yield
- PLNT N/A
- LNTH N/A
- EPS Growth
- PLNT 21.55
- LNTH N/A
- EPS
- PLNT 2.11
- LNTH 3.53
- Revenue
- PLNT $1,129,218,000.00
- LNTH $1,536,699,000.00
- Revenue This Year
- PLNT $20.79
- LNTH $5.81
- Revenue Next Year
- PLNT $9.98
- LNTH $12.26
- P/E Ratio
- PLNT $44.41
- LNTH $22.69
- Revenue Growth
- PLNT 10.26
- LNTH 12.53
- 52 Week Low
- PLNT $59.16
- LNTH $74.34
- 52 Week High
- PLNT $110.00
- LNTH $126.89
- Technical
- Relative Strength Index (RSI)
- PLNT 44.64
- LNTH 27.93
- Support Level
- PLNT $92.78
- LNTH $78.61
- Resistance Level
- PLNT $102.92
- LNTH $83.60
- Average True Range (ATR)
- PLNT 3.10
- LNTH 3.87
- MACD
- PLNT -0.26
- LNTH -3.13
- Stochastic Oscillator
- PLNT 13.01
- LNTH 1.12
About PLNT Planet Fitness Inc.
Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.